CAS: 54767-75-8; (1S,2R)-2-(Octylamino)-1-(4-Propan-2-Ylsulfanylphenyl)Propan-1-Ol

该化合物是一种血管活性化合物,主要用于管理边缘血管疾病,主要用于管理外缘血管疾病,其行动机制包括通过减少血液粘度和抑制小板块聚集来改进微扩散,从而增强周边血液流动. 硫化物化学上被归类为硫酸衍生物,具有亲脂和水利生物特征,有助于其生物利用率和组织渗透. 该化合物在间歇性闭塞和慢性动脉隔离疾病等条件下的潜在好处已经进行了研究,其在血管音和板块功能上的双重作用使其在血管药理学上成为值得注意的治疗选择.

结构式图片

欧盟法规

C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:EP-2250143-A2
    优先权日:2008-01-25
    标题 :Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

    专利号:EP-2250143-B1
    优先权日:2008-01-25
    标 题 :Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

    专利号:LU-83039-A1
    优先权日:1980-12-24
    标 题 :METHODS OF SYNTHESIS OF 1- (4 ISOPROPYLTHIOPHENYL) -2-N OCTYLAMINOPROPANOL

    专利号:US-7560483-B2
    优先权日:2002-02-19
    标题 :Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof

    专利号:CH-654296-A5
    优先权日:1980-12-24
    标 题:Process for the synthesis of 1-(4-isopropylthiophenyl)-2-(n-octylamino)propanol, of its esters and of its salts

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Chauvet-Monges AM, Faure R, Crevat A. 1H-NMR study of suloctidil-A23187 calcium ionophore interaction. Chem Biol Interact. 1993 Feb;86(2):163-9. doi: 10.1128/EC.00314-12.
    3: Bucchi F, Cerletti C, de Gaetano G. Inhibition of platelet thromboxane generation by suloctidil in man. Haemostasis. 1986;16(5):362-8. Japanese. Japanese. Japanese. Japanese. Polish.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知